Inflammatory bowel diseases in Faroese-born Danish residents and their offspring:further evidence of the dominant role of environmental factors in IBD development by Hammer, T. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Inflammatory bowel diseases in Faroese-born Danish residents and their offspring
Hammer, T.; Lophaven, S. N.; Nielsen, K. R.; Von Euler-chelpin, M.; Weihe, P.; Munkholm,
P.; Burisch, J.; Lynge, E.
Published in:
Alimentary Pharmacology and Therapeutics
DOI:
10.1111/apt.13975
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC
Citation for published version (APA):
Hammer, T., Lophaven, S. N., Nielsen, K. R., Von Euler-chelpin, M., Weihe, P., Munkholm, P., ... Lynge, E.
(2017). Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of
the dominant role of environmental factors in IBD development. Alimentary Pharmacology and Therapeutics,
45(8), 1107-1114. https://doi.org/10.1111/apt.13975
Download date: 03. Feb. 2020
Inﬂammatory bowel diseases in Faroese-born Danish residents
and their offspring: further evidence of the dominant role of
environmental factors in IBD development
T. Hammer*,† , S. N. Lophaven*, K. R. Nielsen‡,§, M. von Euler-Chelpin*, P. Weihe†, P. Munkholm¶, J. Burisch¶ &
E. Lynge*
*Department of Public Health,
University of Copenhagen,
Copenhagen, Denmark.
†Department of Occupational
Medicine and Public Health, The
Faroese Hospital System, Torshavn,
Faroe Islands.
‡Medical Centre, National Hospital,
Torshavn, Faroe Islands.
§Genetic Biobank, Torshavn, Faroe
Islands.
¶Department of Gastroenterology,
North Zealand Hospital, Copenhagen,
Denmark.
Correspondence to:
Dr T. Hammer, Department of Public
Health, University of Copenhagen,
Øster Farimagsgade 5,
DK 1014 Copenhagen K, Denmark.
E-mail: tuha@sund.ku.dk
Publication data
Submitted 27 October 2016
First decision 24 November 2016
Resubmitted 16 January 2017
Accepted 16 January 2017
EV Pub Online 8 February 2017
The Handling Editor for this article was
Professor Peter Gibson, and it was
accepted for publication after full
peer-review.
SUMMARY
Background
The incidence of inﬂammatory bowel disease (IBD) is record high in the
Faroe Islands, and many Faroese emigrate to Denmark, where the IBD inci-
dence is considerably lower.
Aim
To study the IBD incidence in ﬁrst-, second- and third-generation immi-
grants from the Faroe Islands to Denmark to assess the extent to which the
immigrants adopt the lower IBD incidence of their new home country.
Methods
Data on Faroese-born Danish residents and their children were retrieved
from the Danish Central Population Register for 1980–2014. Incident IBD
cases were identiﬁed from the Danish National Patient Register. Standard-
ised Incidence Ratios (SIRs) were used to compare the IBD risk in immi-
grants with that of Danes. 95% conﬁdence intervals (CI) were calculated
using the square-root transform.
Results
First-generation Faroese immigrants had a higher IBD incidence than
Danes, SIR 1.25 (95% CI, 0.97–1.59) for men and 1.28 (95% CI, 1.05–1.53)
for women. This excess risk derived from ulcerative colitis (UC), SIR 1.44
(95% CI, 1.10–1.87) for men and 1.36 (95% CI, 1.09–1.68) for women. No
excess risk was found for Crohn’s disease (CD). The UC risk was nearly
doubled during the immigrants’ ﬁrst 10 years in Denmark; SIR 2.13 (95%
CI, 1.52–2.92) for men and 1.63 (95% CI, 1.19–2.18) for women.
Conclusions
Although some impact of genetic dilution cannot be excluded, our ﬁndings
indicate importance of gene-environment interplay in UC, as the excess UC
risk in Faroese immigrants to Denmark disappeared over time and over
one generation in men and over two generations in women.
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INTRODUCTION
Inﬂammatory bowel diseases (IBD) are generally hypoth-
esised to be caused by a combination of genetic pre-dis-
positions and environmental inﬂuences.1 Recent studies
do, however, indicate that the genetic pre-disposition
may play a minor role than previously thought. In
updated data for Swedish twins, Haldvarson2 found the
genetic component in Crohn’s disease (CD) to be weaker
than reported before. Furthermore, comparison of CD
patients, their ﬁrst-degree relatives, and healthy controls
for known IBD genetic risk scores showed that the ﬁrst-
degree relatives had an increased CD-speciﬁc genetic
risk, but their general IBD genetic risk was similar to
that of the healthy controls.3
Large population-based cohort studies from Canada4
and Sweden5 have shown that immigrants from low-
and middle-income countries have a lower incidence of
IBD than that of long-term inhabitants of these two
high-income countries. Children of immigrants to these
countries had an incidence of CD that was closer to,
but still signiﬁcantly lower, than that of the long-term
inhabitants; while their incidence of ulcerative colitis
(UC) tended to catch up with that of the long-term
inhabitants. As the low risks of immigrant groups
approached the higher risk of the receiving country
within two generations, the data indicated that the inci-
dence of IBD, and in particular of UC, was strongly
modiﬁable by the lifestyle and/or environment of the
new country.
However, given that the introduction of an exposure
is associated with an increased risk of a disease, a stron-
ger support for the causation hypothesis may be
revealed, if the risk of the disease also decreases once the
exposure ceases.6 The IBD incidence has increased in the
Faroe Islands during the past 50 years.7 In this respect,
the development in the Faroe Islands resembles that of
other countries undergoing Westernisation.8 At present,
the Faroe Islands has the highest IBD incidence in Eur-
ope with 84 per 100 000,9, 10 a level clearly above that of
other Nordic countries, for example, 24 per 100 000 in
Denmark.9 At the same time, the Faroe Islands are part
of the Danish realm, and many Faroese move to Den-
mark for education and employment. In 2015, a total of
48 600 persons lived in the Faroe Islands,11 while 11 500
persons of Faroese origin lived in Denmark.12
On this background, we hypothesised that persons of
Faroese origin living in Denmark have a higher IBD
incidence than presently found in Denmark.10 Further-
more, we hypothesised that children and grandchildren
of immigrants have a lower incidence than their forefa-
thers, thus we undertook a nationwide, population-based
cohort study of IBD incidence in ﬁrst-, second- and
third-generation of Faroese immigrants to Denmark.
MATERIAL AND METHODS
Study population
In this nationwide, population-based cohort study, data
were retrieved from the Danish Central Population
Register (CPR), which was founded in 1968 and includes
data on all persons with a permanent address in Den-
mark at any point in time since 1968. The CPR includes
information on country of birth, and for immigrants the
country of emigration and immigration date, and a par-
ent-child link enabling the construction of families. We
retrieved data on all Faroese-born residents in Denmark,
their children and their grandchildren, if living in Den-
mark. The CPR is daily updated on vital status and
migration, and the unique 10-digit Civil Personal
Register (CPR) numbers enables linkage to other Danish
registers.13
From the CPR, data were retrieved for Faroese immi-
grants deﬁned as: The Faroe Islands being the country of
birth or/and the Faroe Islands being the country of emi-
gration (ﬁrst-generation immigrants); and for children of
immigrants deﬁned as: a person having at least one
immigrated parent (second-generation immigrants); and
for grandchildren of immigrants deﬁned as a person
having at least one immigrated grandparent (third-gen-
eration immigrants). For each person, information on
gender, date of birth, dates of immigration(s) and emi-
gration(s) and date of death was retrieved. Person years
(pys) were accumulated from 1 January 1980 or from
date of ﬁrst immigration to Denmark whichever came
last; until date of emigration, death, contraction of dis-
ease, or 31 December 2014 whichever came ﬁrst. Re-
immigration was frequent and a given person could
therefore accumulate pys in more than one risk period.
Second- and third-generation also started accumulating
pys from date of birth. For the entire Danish population,
the pys for each calendar year were calculated using the
number of inhabitants in the middle of the calendar
year. Population data for the Danish population was
available from Statistics Denmark.
Diagnoses of CD or UC are recorded in the Danish
National Patient Register, which was founded in 1977
and includes information from hospitals on all in-
patients in somatic wards, and since 1995 also on all
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patients in psychiatric wards, and on all out- and emer-
gency room patients. The International Classiﬁcation of
Diseases, version 8 (ICD-8) was used until 1994, where
it was replaced by the 10th version (ICD-10).14 For CD
the following codes were used 563.00–563.09 and K50–
K50.9. The UC codes were; 563.19, 569.04 and K51–
K51.9.15, 16 A person became a case on the ﬁrst date
within his/her risk period(s), he/she was registered with
one of these diagnoses. To avoid inclusion of prevalent
cases, we excluded cases in persons already known with
an IBD diagnosis in the patient register prior to 1980.
Statistical analysis
Standardised Incidence Ratios (SIRs) were calculated as
the observed numbers of IBD, CD and UC, respectively,
in a given immigrant group divided by the expected
numbers calculated from the accumulated pys and the
incidence rates for IBD, CD and UC in the Danish pop-
ulation. Standard rates were calculated by gender, 5-year
age groups and 5-year calendar periods. The 95% conﬁ-
dence intervals for SIRs were calculated using the
square-root transform.
In our study, a diagnosis of IBD at the age of 19 years
or younger was deﬁned as a paediatric/adolescent case,
in correspondence with the limit set on almost half of
the previous studies.17 SIRs were calculated from the age
of 20 years and above. Furthermore, SIRs were calculated
by time living in Denmark divided into <10 years and
>10 years. It should be noted though that the CPR-data
were left censored to 1980. This means that there will be
a certain degree of misclassiﬁcation on this variable,
because some persons can have immigrated to Denmark
prior to 1980. It would not have helped to restrict the
analysis to persons with a record of immigration after 1
January 1980, because these persons could easily have
lived in Denmark also in one or more period(s) prior to
1980.
Ethics
This is a register-based research project with no contact
to patients, their relatives or treating physicians. The
Danish Data Protection Agency approved the study,
journal no: 2014-41-3538. Data from CPR and the Dan-
ish National Patient Register were obtainable via Statis-
tics Denmark.
RESULTS
The cohort included 57 373 persons of Faroese origin
contributing 812 196 pys. First-generation Faroese immi-
grants included 26 408 persons and 324 680 pys;
second-generation 19 987 persons and 330 109 pys; and
third-generation 10 978 persons and 157 381 pys
(Table 1). Men and women in the ﬁrst-generation spent
86% and 88%, respectively, of their life in Denmark.
In the second generation, both genders spent 91%, and
in the third-generation the percentage of time spent in
Denmark was 98% for both genders (Table 1). In total,
180 incident IBD cases were observed in ﬁrst-generation
immigrants, 122 in second generation and 42 in third-
generation (Tables 2 and 3).
For ﬁrst-generation male immigrants from the Faroe
Islands to Denmark, the SIR for CD was 0.81 (95% CI,
0.45–1.34), for UC, it was 1.44 (95% CI, 1.10–1.87), and
for IBD 1.25 (95% CI, 0.97–1.59) (Table 2). The SIRs
were 1.74 (95% CI, 1.27–2.33); 0.72 (95% CI, 0.28–1.49);
and 2.13 (95% CI, 1.52–2.92), respectively, for the immi-
grants during their ﬁrst 10 years in Denmark, and 0.78
(95% CI, 0.48–1.19); 0.91 (95% CI, 0.39–1.80); and 0.82
(95% CI, 0.48–1.32); respectively, for stays beyond
10 years (Figure 1). In second-generation male immi-
grants, the SIRs were 0.81 (95% CI, 0.47–1.30), 1.01
(95% CI, 0.71–1.40), and 0.96 (95% CI, 0.71–1.26)
respectively. The majority of second-generation immi-
grants had one Faroese parent only, but those with two
Faroese parents also had lower point estimates than ﬁrst-
generation immigrants. The third-generation male immi-
grants had SIRs of 1.12 (95% CI, 0.53–2.10), 0.87 (95%
CI, 0.39–1.66), and 0.97 (95% CI, 0.55–1.57) respectively.
The excess risks of UC and the borderline excess risk of
IBD in ﬁrst-generation immigrants were found only in
men 20 years or above.
For ﬁrst-generation female immigrants, the SIR for
CD was 1.00 (95% CI, 0.70–1.40); for UC, it was 1.36
(95% CI, 1.09–1.68) and for IBD, it was 1.28 (95% CI,
1.05–1.53) (Table 3).
The SIRs were 1.51 (95% CI, 1.16–1.94); 1.12 (95%
CI, 0.68–1.72); and 1.63 (95% CI, 1.19–2.18), respec-
tively, for the immigrants during their ﬁrst 10 years in
Denmark, and 1.07 (95% CI, 0.80–1.41); 0.89 (95% CI,
0.50–1.47); and 1.15 (95% CI, 0.83–1.56); respectively,
for stays beyond 10 years. In the second generation, the
SIRs were 0.92 (95% CI, 0.60–1.36), 1.29 (95% CI, 0.97–
1.69), and 1.18 (95% CI, 0.92–1.48) respectively. In con-
trast to the pattern in men, second-generation immi-
grants with two Faroese parents had higher point
estimates than those with one Faroese parent only. In
the third-generation female immigrants, the SIRs were
1.83 (95% CI, 1.08–2.90), 1.18 (95% CI, 0.62–2.02), and
1.46 (95% CI, 0.95–2.14) respectively. The excess risks of
UC and IBD in ﬁrst-generation immigrants were found
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in women both below and above 20 years of age. The
borderline signiﬁcant excess risk of UC in second-gen-
eration immigrants was found only in women 20 years
and above. The excess risk of CD in third-generation
immigrants was found in women both below and above
the age of 20 years, but the numbers did not reach sta-
tistical signiﬁcance when divided by age.
DISCUSSION
Our study based on nationwide data demonstrated that
ﬁrst-generation Faroese immigrants to Denmark had an
about 25% higher incidence of IBD than the Danish
population. This excess risk derived exclusively from UC,
where the Faroese immigrants had a 44% higher inci-
dence than Danes, while there was no difference between
the two populations in the incidence of CD. The excess
risk of UC was nearly doubled during the immigrants’
ﬁrst 10 years in Denmark. After 10 years in Denmark
the immigrants’ UC risk was similar to that of Danes.
For women, but not for men, the excess risk of UC pre-
vailed among second-generation immigrants in adult age,
especially among those with two Faroese parents. All
third-generation immigrants had the same risk of UC as
the Danish population. The immigrants of Faroese origin
over three generations thus adapted the lower UC risk of
their new home country. Surprisingly, third-generation
female, but not male, immigrants had an excess risk of
CD as compared to Danes.
To our knowledge, this is the ﬁrst nationwide study of
IBD incidence among immigrants from a high-risk coun-
try to a country with a lower risk, although in an inter-
national perspective Denmark is also a high-risk
country.10 Studies of IBD in migrants date back to the
famous study by Probert et al., from 1992 on IBD in
migrants of South Asian descent into the city of Leicester
in the United Kingdom.18 Recently, two nationwide
Table 1 | First, second and third-generation immigrants from the Faroe Islands to Denmark by gender and year of
birth. Person years (pys) for the same groups by calendar period and age
First-generation Second-generation Third-generation
Year of birth Men (n) Women (n) Total (n) Men (n) Women (n) Total (n) Men (n) Women (n) Total (n)
≤1949 2075 3291 5366 12 1 13 0 0 0
1950–59 1441 1660 3101 544 386 930 0 0 0
1960–69 2143 2328 4471 1320 1279 2599 4 2 6
1970–79 2228 2557 4785 1481 1390 2871 77 73 150
1980–89 2144 2450 4594 1661 1567 3228 850 790 1640
≥1990 1861 2230 4091 5226 5120 10346 4764 4418 9182
All persons 11892 14516 26408 10244 9743 19987 5695 5283 10978
Current period (pys)
1980–89 27047.7 41758.7 68806.4 30546.9 28036.1 58583.0 3779.1 3440.8 7219.9
1990–99 40322.7 56223.9 96546.6 45231.0 42641.4 87872.4 16838.8 15585.1 32423.9
2000–09 41926.6 60029.1 101956 57800.6 56355.8 114156 35757.5 33334.1 69091.6
2010–14 23940.4 33431.0 57371.4 34687.8 34809.6 69497.4 25220.0 23424.8 48644.7
Current age (pys)
0–19 22291.2 24304.4 46595.5 83008.4 81377.1 164386 71507.2 66598.3 138106
20–29 30234.3 41132.0 71366.3 37147.3 37033.6 74179.9 8954.1 8116.6 17070.7
30–39 25359.5 33028.8 58388.2 27201.8 25503.4 52705.2 1088.1 1021.5 2109.6
40–49 19244.0 28825.2 48069.2 15637.0 14103.6 29740.6 42.2 47.8 90.0
50–59 15270.0 24133.0 39403.0 4990.4 3739.2 8729.7 3.8 0.6 4.3
60–69 11447.6 19450.4 30897.9 281.4 87.0 368.4 0 0 0
70–79 6630.4 13203.4 19833.7 0 0 0 0 0 0
80+ 2760.5 7365.7 10126.2 0 0 0 0 0 0
% of life in DK
Men Women Men Women Men Women
(n) (%) (n) (%) (n) (%) (n) (%) (n) (%) (n) (%)
11892 86 14515* 88 10237† 91 9732‡ 91 5688§ 98 5275¶ 98
Individuals were excluded due to missing information on pys for *one woman, †seven men, ‡eleven women, §seven men, ¶eight
women.
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Table 2 | Standardised incidence ratio (SIR) of CD, UC and IBD for male ﬁrst-, second-, and third-generation
immigrants from the Faroe Islands to Denmark
Men
CD UC IBD
Obs. Exp. SIR (95% CI) Obs. Exp. SIR (95% CI) Obs.* Exp. SIR (95% CI)
First 15 19 0.81 (0.45–1.34) 56 39 1.44 (1.10–1.87) 66 53 1.25 (0.97–1.59)
First: <10 years in DK 7 10 0.72 (0.28–1.49) 39 18 2.13 (1.52–2.92) 45 26 1.74 (1.27–2.33)
>10 years in DK 8 9 0.91 (0.39–1.80) 17 21 0.82 (0.48–1.32) 21 27 0.78 (0.48–1.19)
Second 17 21 0.81 (0.47–1.30) 37 36 1.01 (0.71–1.40) 50 52 0.96 (0.71–1.26)
Second: one parent 17 18 1.00 (0.60–1.53) 32 31 1.03 (0.70–1.45) 45 44 1.01 (0.74–1.35)
Second: two parents 0 3 NA 5 5 0.94 (0.30–2.22) 5 8 0.65 (0.21–1.54)
Third 10 9 1.12 (0.53–2.10) 9 10 0.87 (0.39–1.66) 16 17 0.97 (0.55–1.57)
Age 0–19
First 1 2 0.50 (0.000–2.84) 1 2 0.43 (0.000–2.44) 2 4 0.51 (0.05–1.86)
Second 3 6 0.48 (0.09–1.41) 8 7 1.14 (0.49–2.26) 11 12 0.92 (0.45–1.64)
Second: one parent 3 5 0.60 (0.11–1.70) 7 6 1.18 (0.47–1.45) 10 10 0.98 (0.47–1.81)
Second: two parents 0 1 NA 1 1 0.93 (0.00–5.31) 1 2 0.54 (0.00–3.10)
Third 8 5 1.48 (0.63–2.92) 5 6 0.86 (0.27–2.02) 11 10 1.10 (0.54–1.97)
Age 20+
First 14 17 0.85 (0.46–1.43) 55 37 1.50 (1.13–1.95) 64 49 1.31 (1.01–1.68)
Second 14 15 0.95 (0.52–1.60) 29 29 0.98 (0.66–1.41) 39 40 0.97 (0.69–1.33)
Second: one parent 14 13 1.11 (0.61–1.87) 25 25 0.99 (0.64–1.46) 35 34 1.02 (0.71–1.42)
Second: two parents 0 2 NA 4 4 0.95 (0.25–2.45) 4 6 0.69 (0.18–1.78)
Third 2 3 0.73 (0.07–2.69) 4 5 0.88 (0.23–2.29) 5 7 0.77 (0.24–1.80)
* Cases of Crohn’s disease and UC do not add to the number of IBD cases as some patients had both diagnoses. NA 95% CI
cannot be calculated using the square-root transform. DK, Denmark.
Table 3 | Standardised Incidence Ratio (SIR) of CD, UC and IBD for female ﬁrst-, second-, and third-generation
immigrants from the Faroe Islands to Denmark
Women
CD UC IBD
Obs. Exp. SIR (95% CI) Obs. Exp. SIR (95% CI) Obs.* Exp. SIR (95% CI)
First 35 35 1.00 (0.70–1.40) 86 63 1.36 (1.09–1.68) 114 89 1.28 (1.05–1.53)
First: <10 year in DK 20 18 1.12 (0.68–1.72) 45 28 1.63 (1.19–2.18) 63 42 1.51 (1.16–1.94)
>10 years in DK 15 17 0.89 (0.50–1.47) 41 36 1.15 (0.83–1.56) 51 48 1.07 (0.80–1.41)
Second 25 27 0.92 (0.60–1.36) 53 41 1.29 (0.97–1.69) 72 61 1.18 (0.92–1.48)
Second: one parent 18 23 0.80 (0.47–1.26) 42 35 1.21 (0.87–1.64) 56 51 1.09 (0.82–1.41)
Second: two parents 7 4 1.60 (0.63–3.32) 11 6 1.71 (0.85–3.07) 16 10 1.65 (0.94–2.69)
Third 18 10 1.83 (1.08–2.90) 13 11 1.18 (0.62–2.02) 26 18 1.46 (0.95–2.14)
Age 0–19
First 2 3 0.67 (0.06–2.46) 5 3 1.49 (0.47–3.49) 7 6 1.21 (0.48–2.51)
Second 9 7 1.23 (0.56–2.34) 9 8 1.09 (0.49–2.07) 16 14 1.13 (0.64–1.84)
Second: one parent 7 6 1.14 (0.45–2.37) 5 7 0.73 (0.23–1.71) 11 12 0.93 (0.46–1.67)
Second: two parents 2 1 1.63 (0.15–5.98) 4 1 2.86 (0.74–7.39) 5 2 2.10 (0.66–4.94)
Third 9 5 1.67 (0.76–3.18) 8 6 1.27 (0.54–2.52) 14 10 1.35 (0.73–2.26)
Age 20+
First 33 32 1.04 (0.71–1.46) 81 60 1.35 (1.08–1.68) 107 84 1.28 (1.05–1.55)
Second 16 20 0.81 (0.46–1.32) 44 33 1.34 (0.98–1.80) 56 47 1.19 (0.90–1.55)
Second: one parent 11 16 0.66 (0.33–1.19) 37 28 1.33 (0.94–1.84) 45 40 1.13 (0.83–1.52)
Second: two parents 5 4 1.38 (0.44–3.25) 7 5 1.39 (0.55–2.89) 11 7 1.50 (0.75–2.70)
Third 7 4 1.98 (0.78–4.10) 5 4 1.05 (0.33–2.46) 12 7 1.61 (0.83–2.83)
* Cases of Crohn’s disease and UC do not add to the number of IBD cases as some patients had both diagnoses. DK: Denmark.
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studies have assessed the IBD incidence in immigrants
from low-risk to high-risk countries. A Canadian study
showed that the incidence of UC among immigrants was
0.42 (95% CI, 0.33–0.53) as compared to that of the
Canadian population, but this relative incidence
increased to 0.78 (95% CI, 0.60–1.01) in their children.
The same trend was observed for CD, where immigrants
had a relative incidence of 0.25 (95% CI, 0.19–0.32),
which increased to 0.49 (95% CI, 0.38–0.63) in their chil-
dren.4 A study from Sweden found similar results, as the
incidence of UC in immigrants was 0.81 (95% CI, 0.77–
0.85) as compared to that of the Swedish population, but
0.95 (95% CI, 0.89–1.02) in their children. For CD, the
relative incidence was 0.75 (95% CI, 0.71–0.80), and for
their children, it was 0.91 (95% CI, 0.85–0.98).5
The Canadian and Swedish studies covered immi-
grants from low-risk to high-risk countries. In these
studies, ﬁrst-generation immigrants had a deﬁcit risk
both for CD and UC, and these deﬁcit risks diminished
among their children. The introduction of an exposure
thus manifested itself over one generation. In our study,
ﬁrst-generation immigrants had an excess risk of UC
during their ﬁrst 10 years in Denmark, and this excess
risk disappeared over time and over one generation in
men and over two generations in women. The removal
of an exposure thus manifested itself over one-to-two
generations. Together these studies form a strong
evidence for the importance of – so far unidentiﬁed –
environmental exposures in the aetiology of UC. In the
analysis, we controlled for sex, age, and calendar period,
but we were not able to control for other risk factors as
these data are not available in Danish registers. It should
also be noted that the decreased risk from ﬁrst to sec-
ond-generation immigrants could in part be due to
genetic dilution as the majority of second-generation
immigrants had one parent only of Faroese origin. In
second-generation immigrants with two parents of Faro-
ese origin, the men had no excess IBD risk as compared
with Danes, but there was an indication of an excess risk
in women. A longer follow-up of the cohort will show
whether this reﬂects true differences or a random varia-
tion due to small numbers.
It is noteworthy that in our previous study of time
trends in IBD incidence in the Faroe Islands, we found a
rapid increase over time in the UC incidence, while the
trend for CD incidence showed a more modest increase.
Furthermore, for CD patients’ disease was primarily
located in the colon (L2)7 and the average age at onset is
higher in the Faroe Islands than in the rest of Europe.10
IBD is believed to occur in genetically pre-disposed indi-
viduals.19 The genetic background for the high incidence
in the Faroe Islands is still unknown, but the innate risk
of developing IBD is likely to be higher compared to
other populations. The Faroe Islands is an autonomous
country within the Kingdom of Denmark with Danish
rule dating back to the mid 1500s, and Danish trade
monopoly until the mid 1800s. The Faroese population
originates in part from Scandinavia, and – in particular
for the female part – from the British Isles.20 Neverthe-
less, the Faroese population has been isolated and is
genetically relatively homogeneous, with some rare dis-
ease syndromes attributable to founder mutations, as for
instance carnitine transporter deﬁciencies,21 glycogen
storage disease type IIIA,22 and cystic ﬁbrosis.23
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incidence ratio (SIR) of
ulcerative colitis in Faroese
immigrants to Denmark.
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parent, one or two parent(s)
of Faroese origin.
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However, genetics alone cannot explain the recent
steep increase in IBD incidence in the Faroe Islands.7
Differences in diet are considered to be the most topical
and likely factors in explaining the geographical variation
and rising incidence of IBD.24 The intake of ﬁsh in
adults is higher in the Faroe Islands25 than in Den-
mark.26 Therefore, despite the difference in latitude
between the Faroe Islands (62° 000 N) and Denmark
(55–57° 000 N) and the consequential difference in solar
exposure, vitamin D deﬁciency (= <50 nmol/L) in elderly
people has been found to be at the same level in the two
countries; 54% in the Faroe Islands,25 and 55% in Den-
mark.27 While IBD patients have been found to have
high prevalence of vitamin D deﬁciency,28 this factor is
unlikely to explain the higher IBD incidence in the Faroe
Islands than in Denmark.
Nevertheless, westernisation has changed the living
conditions in the Faroe Islands during the past 50 years.
The traditional diet of ﬁsh, lamb and pilot whale meat
has changed to include a broader variety of imported
foods. This means, however, that the present dietary pat-
tern in the Faroe Islands is fairly similar to the present
dietary pattern in Denmark. It is therefore unlikely that
the westernisation of the dietary pattern in the Faroe
Islands can explain both the increasing IBD incidence in
the Faroe Islands, and the decreasing IBD incidence in
Faroese immigrants to Denmark. At present, we have no
suggestion for the possible aetiological agent(s) behind
the high IBD risk in the Faroese population. We are
currently investigating the IBD risk in the Faroese
mother-child cohorts,29 and we hope that this further
characterisation of high-risk subgroups may provide
clues to this puzzle. It should also be taken into account
that risk factors may affect native and migrant popula-
tions differently, as seen for instance in the different risk
proﬁles of IBD patients in Australia for migrants of mid-
dle east origin and for natives of caucasian origin.30
It is a strength of the study that all risk periods could
be measured accurately due to the availability of com-
plete im- and emigration histories in the Danish popula-
tion register. The use of Danish National Patient
Register data for identiﬁcation of incident IBD cases
both among the immigrants and among the Danes
ensured that the same case deﬁnitions were used for the
numerator and for the denominator. Our study had,
however, also some limitations. We deﬁned an incident
IBD case as the ﬁrst time a person had either an in- or
an out-patient contact with the relevant diagnosis in the
Danish National Patient Register. This deﬁnition does,
however, lead to a higher IBD incidence than in the
ECCO-EpiCom study,9 where patients had to meet the
Copenhagen Diagnostic Criteria based on clinical symp-
toms, endoscopic or radiological evidence or mucosal
biopsies. The ECCO-EpiCom age-standardised rate
(European Standard Population) was 24 per 100 000 for
Denmark, while this rate was 45 per 100 000 in our
data. For this reason, we were not able to compare our
IBD incidence data for the immigrants with the available
rates from the Faroese population, as these rates were
generated based on the Copenhagen Diagnostic Criteria.7
This reﬂects the inaccuracy of using the routine hospital
discharge diagnosis. But diagnoses according to the
Copenhagen Criteria were not available in the register
data. Furthermore, the purpose of the present study was
to compare the IBD risk of Faroese immigrants with that
of Danes in general. Using the register data only, we
ensured that potential diagnostic misclassiﬁcations
affected the numerator (observed cases in Faroese immi-
grants) and the denominator (expected cases in Faroese
immigrants) to the same extent.
Although we included all Faroese immigrants to Den-
mark, some numbers were small, which could result in
random ﬁndings. It will in particular be important to fol-
low-up on the observed difference between second-
generation men and women with two parents of Faroese
origin, and on the excess risk of CD in third-generation
female immigrants.
In conclusion, this population-based study showed an
excess risk of UC incidence in Faroese ﬁrst-generation
immigrants to Denmark. This excess risk diminished
over time and over generations, faster for men than for
women, and the UC incidence of third-generation immi-
grants was in line with that of the Danish population.
Although the fact that the IBD risk was still high in
female second-generation immigrants with two Faroese
parents could point to some genetic dilution, the general
pattern supports the causation hypothesis of environ-
mental risk factors in IBD and stresses that the gene-
environment interaction in the Faroese population is of
importance. Future research should focus on identiﬁca-
tion of these risk factors.
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